Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Amortization of Deferred Charges: 2016-2017

Historic Amortization of Deferred Charges for ProPhase Labs (PRPH) over the last 1 years, with Mar 2017 value amounting to -$10,000.

  • ProPhase Labs' Amortization of Deferred Charges fell 66.67% to -$10,000 in Q1 2017 from the same period last year, while for Mar 2017 it was -$28,000, marking a year-over-year change of. This contributed to the annual value of -$10,000 for FY2017, which is 58.33% up from last year.
  • According to the latest figures from Q1 2017, ProPhase Labs' Amortization of Deferred Charges is -$10,000, which was down 66.67% from -$6,000 recorded in Q4 2016.
  • In the past 5 years, ProPhase Labs' Amortization of Deferred Charges ranged from a high of -$6,000 in Q1 2016 and a low of -$10,000 during Q1 2017.
  • Moreover, its 2-year median value for Amortization of Deferred Charges was -$6,000 (2016), whereas its average is -$6,800.
  • Data for ProPhase Labs' Amortization of Deferred Charges shows a maximum YoY crashed of 66.67% (in 2017) over the last 5 years.
  • ProPhase Labs' Amortization of Deferred Charges (Quarterly) stood at -$6,000 in 2016, then slumped by 66.67% to -$10,000 in 2017.
  • Its last three reported values are -$10,000 in Q1 2017, -$6,000 for Q4 2016, and -$6,000 during Q3 2016.